Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?

Kanavos, Panos; Reinhardt, Uwe
May 2003
Health Affairs;May/Jun2003, Vol. 22 Issue 3, p16
Academic Journal
What can be learned from international experience of efforts to control spending and to improve efficiency and access in pharmaceutical markets? Policymakers tend to reinvent many policies to control the behavior of patients, doctors, and industry, despite a lack of evidence of those policies' cost-effectiveness. There is an emerging consensus that reimbursement in public and private health care systems should be informed by evidence of the cost-effectiveness of treatments and that utilization should be constrained by budget caps and information systems. Whatever the policy chosen, evaluation is as essential as it is rare.


Related Articles

  • Public Reporting On Quality In The United States And The United Kingdom. Marshall, Martin N.; Shekelle, Paul G.; Davies, Huw T.O.; Smith, Peter C. // Health Affairs;May/Jun2003, Vol. 22 Issue 3, p134 

    Several recent bills in Congress to add a Medicare prescription drug benefit would allow the use of formularies to control costs. However, there is little empirical evidence of the impact of formularies among elderly and disabled populations. We assess the effect of a closed formulary...

  • International Experience With Prescription Drug Policy.  // Health Affairs;May/Jun2003, Vol. 22 Issue 3, p15 

    To control spending on prescription drugs, health insurance systems abroad have experimented in recent years with a novel form of patient cost sharing called "reference pricing." Under this approach, the insurer covers only the prices of Iow-cost, benchmark drugs in therapeutic clusters that are...

  • FINDING A WAY. Hitti, Miranda // Arthritis Today;May/Jun2000, Vol. 14 Issue 3, p54 

    Offers tips on how to handle prescription drug costs. Disadvantages of skipping or reducing medications; Knowledge of your health-care insurance coverage; Tips when shopping drugs internationally. INSETS: How to Apply for Free Drugs;Asking Your Insurer to Reconsider -- One Doctor's Story.

  • Starter scrips would save time and money. Lancelot, Chris // GP: General Practitioner;5/29/2009, p21 

    In this article the author discusses the efficiency of the starter prescriptions as a cost saving measure for patients in Great Britain. It has been analyzed that indicating the total number of medicines to be taken for a week is efficient because the patient is not asked to make further...

  • Overview of Approaches to Control Prescription Drug Spending in Federal Programs.  // GAO Reports;6/24/2009, preceding p1 

    The article presents the assessments of the Government Accountability Office (GAO) on federal programs to control drug prescription spending in the U.S. It mentions various federal programs that control drug prescription spending such as Federal Employees Health Benefits Program (FEHBP),...

  • YOUR MONEY.  // Health (Time Inc.);Mar2007, Vol. 21 Issue 2, p98 

    The article presents question and answers related to personal finance. One person asks whether he should ask his doctor for a generic drug instead of a more expensive brand name drug when he needs a prescription. He is advised that he should since drug effectiveness experts have found that...

  • The wizarding world of Harry Potter: Potions and prescriptions. MILLER, LAURIE S. // Employee Benefit News;Aug2011, Vol. 25 Issue 10, p14 

    The article offers the author's insights regarding prescription medications which been considered as the magic elixir in curing debilitating diseases. The author says that the cost of prescription drugs are increasing, in which it is important that employers should engage with pharmacy benefit...

  • NHS charges are a mess, say MPs. Cole, Andrew // BMJ: British Medical Journal (International Edition);7/22/2006, Vol. 333 Issue 7560, p163 

    The author reports that Great Britain's House of Commons Health Select Committee has recommended a complete reassessment of the system of charging for health services that may include eliminating prescription charges. The exemptions system that is supposed to be based on income actually exempts...

  • NHS pays too much for branded drugs. Mayor, Susan // BMJ: British Medical Journal (International Edition);2/24/2007, Vol. 334 Issue 7590, p383 

    The article presents the results of a British government report. The report, which was from the Office of Fair Trading, a body that protects consumers' interests in the United Kingdom, found that health services in the United Kingdom are overpaying approximately $980 million a year for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics